Catalyst

Slingshot members are tracking this event:

Phase 1/2 initial data of Genmab's (GMAB) Enapotamab vedotin in Solid tumors to be presented at IASLC 2019 WCLC September 8, 2019

Source Link:
https://ir.genmab.com/news-releases/news-release-details/genmab-announces-preliminary-data-be-presented-iaslc-2019-world

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
GMAB Community voting in process
SGEN Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Sep 08, 2019
Occurred Source:
https://s3.amazonaws.com/virtual_library_video/wclc2019/WCLC2019+Onsite+Program__vF_SEPT1.pdf
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Enapotamab Vedotin, Solid Tumors, Iaslc
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.